Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 170.95
+1.35 (0.80%)
Aug 19, 2026, 5:31 PM CET
Galderma Group AG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,893 | 5,207 | 4,410 | 4,082 | 3,760 | 3,417 |
Other Revenue | 30 | 34 | 30 | 35 | 63.6 | 28.1 |
| 5,923 | 5,241 | 4,440 | 4,117 | 3,824 | 3,445 | |
Revenue Growth | 26.29% | 18.04% | 7.85% | 7.66% | 11.00% | - |
Cost of Revenue | 1,814 | 1,632 | 1,355 | 1,232 | 1,194 | 1,034 |
Gross Profit | 4,109 | 3,609 | 3,085 | 2,885 | 2,630 | 2,411 |
Selling, General & Admin | 2,716 | 2,490 | 2,151 | 1,990 | 1,908 | 1,711 |
Research & Development | 278 | 245 | 260 | 287 | 315.9 | 342.6 |
Other Operating Expenses | -16 | -11 | 3 | 2 | 5.1 | 7.7 |
Operating Expenses | 2,978 | 2,724 | 2,414 | 2,279 | 2,229 | 2,062 |
Operating Income | 1,131 | 885 | 671 | 606 | 400.9 | 349.5 |
Interest Expense | -154 | -173 | -352 | -561 | -398.4 | -352.7 |
Interest & Investment Income | 17 | 13 | 12 | 6 | - | - |
Currency Exchange Gain (Loss) | 12 | -19 | -11 | -29 | 4.8 | 72.5 |
Other Non Operating Income (Expenses) | -28 | -27 | 16 | 31 | 12.9 | -72.8 |
EBT Excluding Unusual Items | 978 | 679 | 336 | 53 | 20.2 | -3.5 |
Merger & Restructuring Charges | -14 | -15 | -15 | -17 | -33.2 | -38 |
Asset Writedown | 4 | -5 | - | -1 | -15.2 | -19 |
Legal Settlements | -27 | -20 | -11 | -24 | -23.7 | -19.1 |
Pretax Income | 941 | 639 | 310 | 11 | -51.9 | -79.6 |
Income Tax Expense | 78 | 26 | 79 | 68 | 45 | 4.6 |
Earnings From Continuing Operations | 863 | 613 | 231 | -57 | -96.9 | -84.2 |
Earnings From Discontinued Operations | - | - | - | - | -1.6 | -72 |
Net Income to Company | 863 | 613 | 231 | -57 | -98.5 | -156.2 |
Minority Interest in Earnings | - | - | - | - | - | 1.9 |
Net Income | 863 | 613 | 231 | -57 | -98.5 | -154.3 |
Net Income to Common | 863 | 613 | 231 | -57 | -98.5 | -154.3 |
Net Income Growth | 128.31% | 165.37% | - | - | - | - |
Shares Outstanding (Basic) | 234 | 236 | 238 | 238 | 5,188 | 5,188 |
Shares Outstanding (Diluted) | 236 | 237 | 238 | 238 | 5,188 | 5,188 |
Shares Change | -0.97% | -0.34% | 0.10% | -95.42% | - | - |
EPS (Basic) | 3.69 | 2.60 | 0.97 | -0.24 | -0.02 | -0.03 |
EPS (Diluted) | 3.65 | 2.58 | 0.97 | -0.24 | -0.02 | -0.03 |
EPS Growth | 129.78% | 165.98% | - | - | - | - |
Free Cash Flow | 1,080 | 1,072 | 360 | 44 | 9.7 | 145.8 |
Free Cash Flow Per Share | 4.58 | 4.52 | 1.51 | 0.18 | 0.00 | 0.03 |
Dividend Per Share | 0.441 | 0.441 | 0.166 | - | - | - |
Dividend Growth | 166.65% | 166.65% | - | - | - | - |
Gross Margin | 69.37% | 68.86% | 69.48% | 70.08% | 68.77% | 69.99% |
Operating Margin | 19.10% | 16.89% | 15.11% | 14.72% | 10.48% | 10.14% |
Profit Margin | 14.57% | 11.70% | 5.20% | -1.39% | -2.58% | -4.48% |
Free Cash Flow Margin | 18.23% | 20.45% | 8.11% | 1.07% | 0.25% | 4.23% |
EBITDA | 1,386 | 1,134 | 891 | 818 | 630 | 567.3 |
EBITDA Margin | 23.40% | 21.64% | 20.07% | 19.87% | 16.48% | 16.47% |
D&A For EBITDA | 255 | 249 | 220 | 212 | 229.1 | 217.8 |
EBIT | 1,131 | 885 | 671 | 606 | 400.9 | 349.5 |
EBIT Margin | 19.10% | 16.89% | 15.11% | 14.72% | 10.48% | 10.14% |
Effective Tax Rate | 8.29% | 4.07% | 25.48% | 618.18% | - | - |